Scientific & Clinical Advisors

Expertise, insight and commitment to deliver on strategy

Opus’ scientific and clinical advisors are leaders in the field of inherited retinal degenerations, with decades of experience caring for affected patients and in clinical trials of genetic therapies. Both groups are chaired by Opus scientific founder, Dr. Jean Bennett.

Scientific Advisors

Jean Bennett, MD, PhD

F.M. Kirby Emeritus Professor of Ophthalmology, Perelman School of Medicine, University of Pennsylvania

Eric A. Pierce, MD, PhD

Chatlos Professor of Ophthalmology and Director of the Ocular Genomics Institute, Massachusetts Eye and Ear and Harvard Medical School

Sanford L. Boye

Co-founder and Chief Technology Officer, Atsena Therapeutics; Associate Scientist and Director, Powell Gene Therapy Center at the University of Florida

Radha Ayyagari, PhD

Professor of Ophthalmology, Pathology and Biomedical Sciences Graduate program and Director of the Shiley Eye Institute Biobank, Shiley Eye Institute and University of California, San Diego

Clinical Advisors

Daniel Chung, DO, MA

Chief Medical Officer, SparingVision

Élise Héon, MD, FRCSC

Henry Brent Chair in Innovative Pediatric Ophthalmology Research and Director of the Ocular Genetics Program and Professor of Ophthalmology, The Hospital for Sick Children and University of Toronto

Bart Leroy, MD, PhD

Professor of Ophthalmology, Ophthalmic Genetics and Visual Electrophysiology and Head of the Ophthalmology department, Ghent University and Ghent University Hospital

José-Alain Sahel, MD

Chair and Distinguished Professor of the Department of Ophthalmology and Director of the Eye Center, University of Pittsburgh Medical Center; and Professor, Sorbonne Medical School